Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04060654 · ClinicalTrials.gov registry record · Phase 4
SUBLOCADE Rapid Initiation Extension Study
A Phase 4 study, sponsored by Indivior.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT04060654 is a Phase 4 study that has completed, run by Indivior. The registered enrollment target is 17 participants.
The verdict
NCT04060654, a Phase 4 study, has completed, sponsored by Indivior.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
A single center, open-label SUBLOCADE treatment extension study in which up to 25 participants diagnosed with moderate to severe opioid use disorder (OUD) could be enrolled.
Interventions
- DRUG Sublocade
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-10-21 |
| Est. Completion | 2020-05-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04060654
The ClinicalTrials.gov registry entry for NCT04060654 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indivior, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sublocade is the first listed.
NCT04060654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04060654 about?
NCT04060654 is a clinical study titled "SUBLOCADE Rapid Initiation Extension Study". A single center, open-label SUBLOCADE treatment extension study in which up to 25 participants diagnosed with moderate to severe opioid use disorder (OUD) could be enrolled.
What is the current status of trial NCT04060654?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2019-10-21. Estimated completion is 2020-05-15.
What interventions are being tested in trial NCT04060654?
The interventions under investigation include: Sublocade (DRUG).
Who is sponsoring clinical trial NCT04060654?
This trial is sponsored by Indivior, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.